GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Upper GI Tract/pH-integrated ultrathin endoscopy for ambulatory GERD monitoring
64

pH-integrated ultrathin endoscopy for ambulatory GERD monitoring

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated May 1, 2025

The pH-integrated ultrathin endoscopy, known as the EndoMonitor System, represents a groundbreaking innovation for ambulatory gastroesophageal reflux disease (GERD) monitoring. This newly developed device integrates real-time pH measurement with direct video imaging of reflux episodes, addressing limitations of traditional pH-impedance catheters, such as subjective interpretation, delayed analysis, and lack of visual correlation with reflux events.

The EndoMonitor is a 2.8 mm ultrathin transnasal endoscope equipped with an antimony pH electrode and a miniature CMOS camera. It connects to mobile devices for live visualization, allowing simultaneous recording of pH changes and reflux events. Preclinical evaluation included in vitro (porcine esophagus-stomach models) and in vivo (miniature pig) experiments, demonstrating superior detection accuracy compared to conventional pH-impedance catheters. The EndoMonitor achieved 100% detection of distal acid, distal mixed, and horizontal acid reflux, outperforming the catheters, which showed significantly lower detection rates. Additionally, it accurately identified proximal reflux events with over 90% accuracy.

The device offers real-time visualization of reflux episodes and pH drops, enabling objective identification of reflux type, height, duration, and composition (acidic vs. mixed) without the need for post-hoc analysis. It also provides insights into esophageal motility and clearance through documentation of post-reflux swallow-induced peristaltic waves (PSPW), critical for assessing reflux burden and mucosal protection. The safety profile was excellent, with no device malfunctions or adverse effects observed during prolonged monitoring.

While preclinical limitations exist, such as the absence of symptomatic human subjects, planned clinical trials aim to validate the EndoMonitor in conscious humans for long-term use. This dual-mode system offers the potential to redefine GERD diagnostics by combining physiologic data and anatomical imaging, setting a new standard for real-time, visualized reflux assessment.

Related Q&A

65

RefluxStop surgery in the treatment of acid reflux

RefluxStop surgery is an innovative and highly effective procedure for the treatment of chronic gastroesophageal reflux disease (GERD), addressing the root causes of acid reflux while minimizing common...

66

H. Pylori Screening After Acute MI: HELP-MI SWEDEHEART Trial

The HELP-MI SWEDEHEART trial was a large, nationwide, cluster-randomized crossover study conducted across 35 hospitals in Sweden to evaluate whether routine screening for Helicobacter pylori (H. pylori) in...

67

Autoimmune Gastritis related NET and Gut Microbitoa- Osaka Study

The Osaka Metropolitan University study explored the relationship between autoimmune gastritis (AIG) and the development of gastric neuroendocrine tumors (NETs), focusing on the role of gut microbiota and...

68

Nonpharmacologic interventions for GERD

Nonpharmacologic interventions for gastroesophageal reflux disease (GERD) refer to therapeutic approaches that do not rely on medications but aim to improve symptoms, enhance lower esophageal sphincter (LES) function,...

69

Bleeding risk , Blood thinners and Esophageal dilation

Esophageal dilation is a procedure used to widen a narrowed esophagus, often performed using tools such as balloon dilators or Savary dilators. While the procedure itself is generally...

70

VOYAGE trial

The VOYAGE trial was a phase 2 clinical study designed to evaluate the efficacy, safety, and tolerability of etrasimod, an investigational oral therapy, in adults with eosinophilic esophagitis...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer